CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Biotech
  • top biotech companies in apac

Biotech 2021

Top 20  BioTech Companies in APAC 2021

Top 20 BioTech Companies in APAC 2021

With the emergence of advanced technologies such as machine learning and artificial intelligence, companies have been focusing on expanding the scope and size of their research while also improving production efficiency— both of which reduce the time it takes for biotech firms to bring new products to market. As a result, there has been an increase in consumer Biotech or Biotech goods aimed at customers rather than biopharma or healthcare companies. While the majority of the industry’s attention is still on medicine, entrepreneurs are developing solutions for everything from food and materials to environmental monitoring.

Furthermore, the advancement of cloud computing technologies has removed the barrier to many biotech breakthroughs. Companies can now store and analyze data without purchasing expensive computer hardware by using cloudbased software. This helps both new as well as large businesses by making it easier and less expensive to allocate resources for new initiatives. Another advantage of cloud computing is that it allows stakeholders from various organizations to collaborate seamlessly. Software solutions that facilitate communication, data sharing, and virtual meetings allow organizations to collaborate regardless of their geographical location, making the research process more accessible to a broader range of stakeholders.

To help companies select the best-of-breed biotech solutions, our distinguished panel comprising CEOs, CIOs ,CMOs, analysts , and the Life Science Review APAC ‘s editorial board have reviewed and selected the Top 20 Biotech Companies in APAC. In our selection process, we have evaluated a vendor’s competency to provide efficient as well as cost effective Biotech solutions and services.

Here, we present you Life Science Review APAC’s “Top 20 Biotech Companies in APAC - 2021”.

Top 20  BioTech Companies in APAC 2021

Nominate a Company

Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.

* 

captcha
Can't read the image? click here to refresh

Thank You!

checkmark

We are glad to receive your nomination. Our editorial team and evaluation panel will review your submission. Thank you for taking the time to highlight an organization driving impactful change in Lifescience Review.

Data not inserted

    top biotech companies in apac

    ★Featured Companies
    CellKey
    CellKey
    Read full profile →
    CellKey is developing Glycoprotein analytics pipeline and data repository(SpAC9) and providing Mass Spec. based Glycoprotein Analysis and Glycoprotein Biomarker discovery and validation services ... read full profile
    PharmAbcine
    PharmAbcine
    Read full profile →
    PharmAbcine is a leading biotech company contributing to human health and wellbeing by providing innovative therapeutic antibodies to patients with unmet needs. Since the last decade, the company has acquired extensive expertise through research collaboration and clinical studies alongside its partners (including Sanofi, MSD, and Roche). Moreover, the company’s research and development workforce has grown to over 50 personnel, more than half of whom hold a master’s degree or higher. The company also has its own antibody library called HuPhage, consisting of over 10 billion different antibodies. ... read full profile
    Rokit Healthcare
    Rokit Healthcare
    Read full profile →
    ROKIT Healthcare is a global regenerative solutions company committed to providing an effective autologous organ regeneration platform using its proprietary 3D bio-fabrication technologies. In the life sciences research market, we supply clean-bench 3D bioprinters "INVIVO"​ as laboratory tools to advance research in tissue engineering, material science, and regenerative medicine. In the clinical market, it is in the development of 3D printing-based clinical platforms that provide personalized therapy in the areas of skin, cartilage, retina, and heart patch regeneration. In summary, ROKIT Healthcare is committed to accelerating the translation of bioprinting technology from the bench to the clinic for improved patient care. ... read full profile
    Abbisko Therapeutics
    Abbisko Therapeutics
    Abbisko Therapeutics is based in Shanghai Zhangjiang Science City. It is a small molecule novel medication research and development company. The firm is dedicated to helping patients by researching and developing innovative treatments for illnesses that have no effective therapy at home or abroad. The company's founders and management team include national "Thousand Talents" and senior professionals. Years of R&D management experience at significant worldwide and local pharmaceutical businesses, including leading and participating in the development of many clinical and commercialised novel products.
    Aprogen
    Aprogen
    By collecting long-term fundamental scientific research results-based protein drug development technologies, The business created the first antibody biosimilar authorised in the nation in 2006, the yihurodo. Bioreactors, protein and antibody drug design methodologies, antibody-drug synthesis efficiency cell technology. They have consistently improved mass manufacturing antibody drug technology and drug effectiveness and pharmacological property analyses. We now have unequalled technical prowess, extensive R&D skills, and manufacturing infrastructure that can compete with huge global pharmaceutical businesses.
    Immvira
    Immvira
    Immvira was founded in Shenzhen China in May of 2015 by Prof. Grace Zhou, formerly a Research Associate Professor at the University of Chicago, and a few other virologists and immunologists as well. The mission of the company is to develop a broad range of anti-cancer therapies based on genetically engineered viruses and augmented by cancer-specific immune factors or chemotherapeutic agents that can be delivered intratumorally or systemically.
    JuiceInnov8
    JuiceInnov8
    JuiceInnov8 is a deep tech startup with a focus on the food biotechnology space. It develops sugar reduction technology with our non-GM microbes for the juice industry to build a better & healthier 100% juice with less sugar & lower calories. At JuiceInnov8, it cultivate and screen through hundreds of microbes from nature to find the perfect natural sugar reducer for the specific type of juice under controlled conditions & selected pathways. Its technology platform will enable juice producers to customize the range of natural sugar reduction from mildly sweet - less sugar to sugar-free - zero calories
    Mesoblast
    Mesoblast
    Mesoblast is using its proprietary technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care and where inflammation plays a central role. The Company’s portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection; REVASCOR® for advanced chronic heart failure; and MPC-06-ID for chronic low back pain due to degenerative disc disease.
    MiRXES
    MiRXES
    They are a Singapore-headquartered biotechnology company focused on improving and saving lives with RNA-powered disease early detection tests. Their story began in early 2000 when their founders pioneered a highly sensitive, specific, and robust detection technology for microRNA (miRNA), the smallest genetic material ever found in humans and other living organisms. Realizing the potential of miRNA-based clinical applications in solving unmet needs in cancer, cardiovascular, metabolic, and infectious diseases, we decided to bring our technology from lab to clinic.
    Modalis Therapeutics
    Modalis Therapeutics
    Modalis is an expert in Genome editing technology, a modality that evolves CRISPR and treats with gene switching. Modalis is an original name that the Company has chosen to hope Company’s proprietary gene modulation technology, CRISPR-GNDM, to be a new modality (therapeutic technology) to assist patients fighting with genetic disorders. It is the key to the treatment of genetic diseases, and the logo of the company name expresses “a gene switch” becoming the target of the CRISPR-GNDM technology.
Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://biotech-apac.lifesciencesreviewapac.com/vendors/top-bio-tech-companies-in-apac-2021.html